US Patent:
20210047323, Feb 18, 2021
Inventors:
- Boston MA, US
Kevin J. Gagnon - Acton MA, US
Jicong Li - Cambridge MA, US
Jennifer Lu - San Diego CA, US
Ales Medek - Winchester MA, US
Muna Shrestha - Belmont MA, US
Michael Waldo - Grafton MA, US
Beili Zhang - San Diego CA, US
Carl L. Zwicker - Wakefield MA, US
Corey Don Anderson - Brighton MA, US
Jeremy J. Clemens - San Diego CA, US
Thomas Cleveland - San Marcos CA, US
Timothy Richard Coon - Carlsbad CA, US
Bryan Frieman - La Jolla CA, US
Peter Grootenhuis - Del Mar CA, US
Sara Sabina Hadida Ruah - La Jolla CA, US
Jason McCartney - Cardiff by the Sea CA, US
Mark Thomas Miller - Rancho Santa Fe CA, US
Prasuna Paraselli - San Diego CA, US
Fabrice Pierre - La Jolla CA, US
Sara E. Swift - San Diego CA, US
Jinglan Zhou - San Diego CA, US
International Classification:
C07D 471/08
Abstract:
Crystalline forms of Compound I:pharmaceutically acceptable salts thereof, and solvates and hydrates thereof are disclosed. Pharmaceutical compositions comprising the same, methods of treating cystic fibrosis using the same, and methods for making the same are also disclosed.